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A B S T R A C T
Dibutylphthalate (DBP) is an environmental pollutant widely used as plasticizer in a variety of industrial ap-
plications worldwide. This agent can be found in personal-care products, children's toy, pharmaceuticals, food
products. Exposure to DBP can occur via ingestion and inhalation as well as intravenous or skin contact. DBP
belongs to the family of endocrine disrupting chemicals (EDCs) and its eﬀects on reproductive system were
demonstrated both in vivo and in vitro. In the present study we evaluated the eﬀects of DBP on human prostate
adenocarcinoma epithelial cells (LNCaP) in order to highlight xenoestrogens inﬂuence on human prostate.
Moreover, we have compared DBP eﬀects with 17β-estradiol action in order to investigate possible mimetical
behaviour. We have assessed the eﬀects of both compounds on the cell viability. After then, we have evaluated
the expression of genes and proteins involved in cell cycle regulation. Furthermore, we have observed the ex-
pression and the cell localization of estrogen (ERs) and androgen (AR) receptors. In conclusion, we have de-
monstrated that DBP interacts with estrogen hormonal receptor pathway but diﬀerently from E2. DBP alters the
normal gland physiology and it is involved in the deregulation of prostate cell cycle.
1. Introduction
Phthalates are heterogeneous group of xenobiotics widely used to
enhance products ﬂexibility, durability and transparency (Alam et al.,
2010; Howdeshell et al., 2007). Phthalate plasticizers are esters of
phthalic acid and based on their alcohol chain length, they may be
divided into two groups: low and high molecular-weight (Barlow et al.,
2004; Barlow, Foster, 2003; Blount et al., 2000). Both of them are not
chemically bound to products and with age, use and ultraviolet light
they can easily end up into the environment (Johnson et al., 2012;
Thomas, Thomas, 1984), therefore, human exposure can occur through
diet, inhalation and dermal absorption (Schettler, 2006; Wormuth
et al., 2006). Many studies corroborate phthalate metabolite presence
in human serum, urine and breast milk (Frederiksen et al., 2011; Göen
et al., 2011; Moody et al., 2013; Wittasek et al., 2011). These com-
pounds are endocrine disruptors: they can aﬀect thyroid signaling and
metabolic homeostasis (Borch et al., 2006; Gray et al., 2000; Lyche
et al., 2009; Zhai et al., 2014) and they are also reprotoxic; their ne-
gative eﬀects for reproductive system depend on their alkyl chain (Fujii
et al., 2005).
Phthalates exposure during sensitive window of perinatal develop-
ment may result in developmental eﬀects in human babies
(Christiansen et al., 2010). The presence of diﬀerent phthalate
monoesters in breast milk seems to be correlated with increased levels
of luteinizing hormone (LH), sex hormone-binding globulin (SHBG) and
with an increased ratio of LH/free testosterone in 3 months age boys
(Main et al., 2005). Furthermore, infant boys, whose mothers presented
elevated levels of phthalate metabolites in urine, have reported shor-
tened anogenital distance (AGD) (Swan et al., 2005).
Men's phthalate exposure has been associated with hypospadias,
gynecomastia, cryptorchidism, abnormal spermiogram and sperm DNA
damage and with abnormal sexual hormones levels; instead, women's
exposure can cause infertility, endometriosis, breast cancer, early me-
narche and breast development and pregnancy complications (De Falco
et al., 2015; Hannon, Flaws, 2015; Heudorf et al., 2007; Kay et al.,
2013; Zhang et al., 2015). Experimental studies on early gestation ex-
posure to phthalates in rats, show that they may display phthalate
syndrome. This syndrome symptoms look like the eﬀects of phthalate
exposure in human male and it is characterized by the presence of
seminiferous tubules with reduced diameter, hypospadias, cryptorch-
idism, reduced anogenital distance and malformation of vas deferens,
epididymis, seminal vesicles and prostate gland (Christiansen et al.,
2010; Kay et al., 2013; Lioy et al., 2015).
Dibutylphthalate (DBP) is short-chain phthalate prepared from
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butanol (Shirai et al., 2013; Wakui et al., 2014, 2013). It is commonly
used in paints, inks, adhesive, insecticides, solvents, cosmetics, per-
fumes and medications (Guo and Kannan, 2013; Hubinger, 2010;
Schettler, 2006; Xu et al., 2014); so human population appears to be
predominantly exposed to it (Barlow, Foster, 2003; Blount et al., 2000).
DBP belongs to the subclass of endocrine disrupting chemicals
(EDCs) that mimic the endogenous estrogens. DBP mainly damages
male reproductive system inducing negative eﬀects on testicular func-
tion and steroidogenesis (Dobrzynska et al., 2011; Kay et al., 2013; Li
et al., 2016). It rapidly crosses the placenta barrier and embryos from
rats in utero exposed show several reproductive abnormalities: hypos-
padias, nipple retention, reduced AGD and retarded testis descent and
spermatogenesis dysfunction (Liu et al., 2012; Silva et al., 2007). DBP in
utero exposure may also causes age-related morphological changes of
Leydig cells smooth endoplasmic reticulum (LCs-ER) corresponding to
reduced testicular testosterone biosynthesis (Motohashi et al., 2016).
The mechanism by which phthalates, including DBP, exert their
actions on reproductive functions are not yet fully cleared. Phthalates
and their metabolites, have been suggested to interfere with normal
steroidogenesis, dropping the expression of steroidogenic enzymes and
disrupting the regulation of cholesterol and lipid homeostasis or insulin
signaling (Barlow et al., 2003; Knez, 2013; Liu et al., 2005; Moody
et al., 2013).
Prostate is an accessory gland of the male reproductive tract. Both
androgens and estrogens hormones play a pivotal role in its diﬀer-
entiation, development and maintenance of adult homeostasis. In vivo
and epidemiological studies suggest a positive relationship between
EDC men exposure and prostate diseases (Alavanja et al., 2003).
In this study, we evaluated the eﬀects of DBP on human adeno-
carcinoma prostate cells (LNCaP). LNCaP cells are a useful prostate
model in vitro because they are hormone responsive and express all
prostate speciﬁc markers (Horoszewicz et al., 1983). We analyzed the
eﬀects of DBP on the expression of genes and proteins that can be al-
tered after exposure to endocrine disruptor chemicals (EDCs). Particu-
larly, we have observed the DBP action on cell viability, the expression
of key genes (MCT4, Ki-67 and cyclin D1) involved in the regulation of
cell proliferation and proteins (mct4, cyclin D1, Bax, Bak) involved in
cell cycle and apoptosis, and the expression and cellular localization of
estrogen ERs (ERα and ERβ) and androgen AR receptors. Cells were
also treated with the endogenous hormone 17 β-estradiol to better
understand exogenous and endogenous compounds involvement in
prostate gland and to investigate possible mimetical behaviour by DBP.
2. Materials and methods
2.1. Cell culture
LNCaP cells (CRL-1740™ American Type Culture Collection,
Manassan, VA) were grown in RPMI 1640 (Sigma-Aldrich), supple-
mented with 10% FBS, 2 mM glutamine, 1X non essential amminoacid,
1X penicillin/streptomycin, 10 µg/mL gentamycin (Euroclone) at 37 °C,
5% CO2 in an humidiﬁed incubator. When 70% conﬂuent, cells were
enzymatically detached with trypsin-edta (Sigma-Aldrich) and seeded
in a new cell culture ﬂasks. The medium was changed every 2 days.
Cells were used from passage 9–20.
Table 1
a) Details of primers used for RT-qPCR, b) Details of primary antibodies used for western blot and immunoﬂuorescence
assays.
a)
Gene Forward Reverse
MCT4 5′-
ACCCACAAGTTCTCCAGTGC-3′
5′-AGCAAAATCAGGGAGGAGGT-3′
Cyclin D1
5′-CGTGGCCTCTAAGATGAAGGA-3′
5′-CGGTGTAGATGCACAAGCTTCTC-3′
Ki-67
5′-CCCGTGGGAGACGTGGTA-3′
5′-TTCCCGTGACGCTTCCA-3′
HPTR1
5′-GACTTTGCTTTCCTTGGTCAGGCA-3′
5′- ACAATCCGCCCAAAGGGAACTGA-3′
b)
Antibody Source Species Dilution
MCT4 sc-50329, Santa
Cruz, CA, USA
Rabbit 1:200
Cyclin D1 ab-74646, Abcam,
Cambridge
Rabbit 1:200
Bak sc-832, Santa Cruz,
CA, USA
Rabbit 1:200
Bax sc52b, Santa Cruz,
CA, USA
Rabbit 1:200
ERα sc544, Santa Cruz,
CA, USA
Rabbit 1:200
ERβ sc-8974, Santa Cruz,
CA, USA
Rabbit 1:200
AR ab-74272, Abcam,
Cambridge
Rabbit 1:300
β-actin sc-7210, Santa Cruz,
CA, USA
Rabbit 1:200
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2.2. Chemicals
Dibutylphthalate (DBP) and 17 β-estradiol (E2) were purchased
from Sigma-Aldrich and dissolved in DMSO. Then, DBP and E2 were
diluted in RPMI 1640 red-phenol free at the concentrations used for the
experiments. Control cells were treated with vehicle (DMSO 0,01%).
2.3. Treatment
LNCaP cells were treated with DBP and E2 from 10−5 M to 10–13 M
for 24 h in order to perform the MTT assay. MTT assay allowed us to
establish DBP and E2 concentration to use for the further experiments.
RT-pPCR and western blot analysis were performed after 24 h of ex-
posure with DBP 10−8 M and E2 10−9 M. Immunoﬂuorescence was
carried out after three diﬀerent times (30 min, 2 h, 4 h) of exposure to
10−8 M DBP and 10−9 M E2.
2.4. MTT assay
MTT assay was performed to evaluate the eﬀects of DBP and E2 on
cell viability. LNCaP cells were cultured at a density of 1,5×104/ well
in 96 multiwell, starved (FBS 1%) for 24 h and treated with DBP and E2
from 10−5 M to 10–13 M for 24 h. Then, 10 µL of MTT were added to
each well for 4 h at 37 °C, 5% CO2. In order to dissolve the formazan
crystals produced in each well, the medium was aspirated and was
added a solution of isopropanol and DMSO (1:1). Then, the assorbance
of the solution was read at 570 nm using a microplate reader. Each MTT
assay was performed in triplicate.
2.5. RNA extraction and RT-qPCR
mRNA expression levels of genes were analyzed using real-time
PCR. Total RNA was extracted from control and treated cells for 24 h
with DBP 10−8 M and E2 10−9 M using PureLink™ RNA Mini Kit (Life
Technologies). TURBO DNA-free™ Kit (Life Technologies) was used for
puriﬁcation from genomic DNA. After puriﬁcation total RNA was
quantiﬁed with a NanoDrop spectrophotometer. cDNAs were synthe-
sized from 1 µg RNA using the High Capacity cDNA Reverse
Transcriptase (Life Technologies) and quantitative PCR (RT-PCR) was
performed using the 7500 Real-Time PCR System and SYBR®Select
Master Mix 2X assay (Applied Biosystem). All primers used, are listed in
the Table 1 and were designed according to the sequences published on
GenBank using Primer Express software version 3.0. The amount of
target cDNA was calculated by comparative threshold (Ct) method and
expressed by means of the 2-ΔΔCt method (Livak and Schmittgen, 2001)
using the housekeeping gene hypoxanthine phosphoribosyltransferase 1
(HPRT1). Three diﬀerent experiments were performed for RT-qPCR and
each sample was tested in triplicate.
2.6. Protein extraction
Proteins were extracted from LNCaP cells after 24 h of treatment
with DBP 10−8 M and E2 10−9 M. Control cells were treated only with
vehicle (DMSO 0.01%). 10 cm cell dishes with conﬂuent LNCaP cells
were placed on ice for 10 min and washed twice with ice cold PBS. Then
PBS-EDTA was added and cells were scraped and transferred to mi-
crocentrifuge tubes. The collected cells were centrifuged at 3000 rpm
for 5 min at 4 °C and pellets were resuspended wit RIPA lysis buﬀer
containing protease and phosphatase inhibitors cocktail (Santa Cruz)
for 30 min. Homogenates were centrifuged at 12,000g for 20 min at
4 °C. Total protein amounts of samples were determined by the BCA
protein assay reagent kit (PIERCE).
2.7. Western blot
50 µg of proteins for each samples were boiled for 5 min in SDS
buﬀer [50 mM Tris-HCl (pH 6.8), 2 g 100 mL−1SDS, 10% (v/v) gly-
cerol, 0.1 g 100 mL−1Bromophenolblue], separated on 10% SDS-PAGE
and transferred to a PVDF membrane for blotting (Trans-Blot® Semi-Dry
Transfer Cell, Biorad). Membranes were incubated for 1 h at room
temperature with blocking buﬀer (TBS, 0.05% Tween-20% and 5%
milk). After blocking, membranes were incubated overnight at 4 °C
with primary antibodies diluted in TBS-T containing 2% milk. Primary
antibodies used were listed in the Table 1. The membranes were wa-
shed four times for 10 min in TBS, 0.05% Tween-20 before a 1 h in-
cubation with secondary antibody diluited in TBS-T containing 2%
milk. Secondary antibody used was goat anti-rabbit IgG (HRP) (1:3000;
Abcam ab-6721). Then, the membranes were washed four times for
10 min and speciﬁc protein bands were detected with chemilumines-
cence using the C-DiGit Chemiluminescent Western Blot Scanner (LI-
COR). Western blot were analyzed using Image Studio Software to de-
termine optical density (OD) of the bands. The OD reading was nor-
malized to β-actin to account for variations in loading. All experiments
were performed in triplicates. Western blots were performed as re-
ported in Zizza et al. (2017).
2.8. Immunoﬂuorescence
LNCaP cells were seeded overnight at a density of 5×104/well in 4-
well chamber slides (Sarstedt, Nürnbrecht, Germany) and after 24 h 1%
FBS, cells were treated with DBP 10−8 M and E2 10−9 M for three
diﬀerent times: 30 min, 2 h and 4 h, instead control cells were treated
only with vehicle (DMSO 0.01%). Then, control and treated groups
were ﬁxed with ice cold methanol for 10 min at RT, permeabilized with
0.4% Triton X-100 in PBS for 10 min at RT, washed in PBS and blocked
in 5% Normal Goat Serum (NGS) for 30 min. Subsequently, cells were
incubated overnight at 4 °C with the primary antibodies: rabbit poly-
clonal anti-human ERα, rabbit polyclonal anti-human ERβ, and rabbit
polyclonal anti-human androgen receptor, diluited in 1% NGS. The day
Fig. 1. MTT assay after 24 h of exposure to dibutylphthalate (DBP) and 17β-estra-
diol (E2) from 10−5 M to 10–13 M. In graphs are reported the absorbencies measured at
570 nm which correlates with number of living cells. (a) DBP induce a decrease of cell
viability at 10−8 M; (b) E2 stimulates prostate cell viability, reaching the most notable
eﬀect at 10−9 M. (**p<0,01; ***p< 0,001).
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after cells were incubated with goat anti-rabbit Alexa Fluor 488 (ab
150077), diluited 1:300 in 1% NGS. Cell nuclei were stained with
0,1 µg/mL Höechst and negative controls were performed by avoiding
incubation with primary antibodies. Fluorescent images were captured
with Axioshop (Carl Zeiss, Milano, Italy) epiﬂuorescence microscope
using a 40x objective. Axiocam MRc5 and the acquisition software
Axiovision 4.7 (Carl Zeiss) were used to take the images in diﬀerent
channels (Alexa Fluor 488, Höechst 33258). Each immunoﬂuorescence
was performed in triplicate and for data analysis diﬀerent ﬁelds were
randomly chosen.
The immunoﬂuorescence was performed as reported in Forte et al.
(2016).
2.9. Statistical analysis
Data showed in graphs are expressed as means± SEM for the in-
dicated number of independent determinations. The statistical sig-
niﬁcance was calculated by the one way ANOVA with Bonferroni's
multiple comparison test and diﬀerences were considered statistically
signiﬁcant when the P values was at least p<0.05. All experiments
were repeated at least three times and performed in triplicate.
3. Results
3.1. MTT Assay
MTT assay was performed to evaluate the eﬀects of DBP and E2 on
cellular viability. We exposed LNCaP cells to DBP and E2 range from
10−5 M to 10–13 M. After 24 h of exposure, DBP induced a decreased
cells viability with the greatest eﬀect at 10−8 M (Fig. 1a). Instead, E2
increased LNCaP viability with the higher eﬀect showed at 10−9 M
(Fig. 1b).
3.2. RT-qPCR analysis
After 24 h of exposure with DBP 10−8 M and E2 10−9M, RT-qPCR
was performed to evaluate expression of genes involved in cell cycle
regulation such as MCT4, Ki67 and Cyclin D1. DBP didn’t interfere on
mRNA levels ofMCT4 (Fig. 2a); on the contrary DBP strongly decreased
expression of Ki67 (Fig. 2b) and Cyclin D1 (Fig. 2c) of 50% and 40%
respectively. Conversely, E2 enhanced MCT4 expression of 30%
(Fig. 2a), and it didn’t signiﬁcantly interfere on Ki67 (Fig. 2b) and
Cyclin D1 expression (Fig. 2c).
3.3. Western blot analysis
Western blot analysis was performed after 24 h of exposure with
DBP 10−8 M and E2 10−9 M in order to evaluate the expression of
MCT4 and Cyclin D1 involved in cell cycle regulation, the expression of
pro-apoptotic proteins such as Bax and Bak and protein expression of
estrogen and androgen receptors. Densitometric analysis were nor-
malized with β-actin (42 kDa).
Western blot results showed MCT4 (43 kDa), Cyclin D1 (33 kDa),
Bax (23 kDa), Bak (30 kDa), ERα (66 kDa), ERβ (56 kDa) and AR
(99 kDa) both in control and treated cells (Fig. 3a).
The densitometric analysis revealed higher levels of MCT4 and
Cyclin D1 proteins in E2 treated cells (Figs. 3b, c) compared to DBP
treated and control cells. Treatment with DBP signiﬁcantly enhanced
both Bax (Fig. 3d) and Bak (Fig. 3e) protein expressions, instead
treatment with E2 signiﬁcantly decreased Bax expression (Fig. 3d) and
didn’t interfere with Bak expression (Fig. 3e).
ERα protein expression was drastically reduced by DBP treatment
(Fig. 3f), in contrast E2 strongly increased its expression (Fig. 3f). Re-
garding to ERβ and AR only the treatment with E2 induced a signiﬁcant
increase of their expressions (Figs. 3g, h).
Fig. 2. qPCR analysis after 24 h of exposure to dibutylphthalate (DBP) 10−8 M and 17β- estradiol (E2) 10−9 M. RT-qPCR was performed to evaluate expression of genes involved in
cell cycle regulation such as MCT4, Ki67 and Cyclin D1. To note the diﬀerent actions on gene expression of DBP and E2 (a, b,c). (*p< 0,05; ** p<0,01; ***p< 0,001).
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3.4. Immunoﬂuorescence
In order to investigate a possible interaction among DBP with es-
trogen and androgen receptors in the cells, we performed immuno-
ﬂuorescence after 30 min, 2 h and 4 h of exposure to DBP 10−8 M and
E2 10−9M.
3.4.1. Localization of ERα
After 30 min of treatment, control cells and treated with DBP and E2
showed ERα in the cytoplasm. After 2 h DBP did not aﬀect ERα loca-
lization, that was localized in the cytoplasm as in control cells. ERα
shifted from cytoplasm to nucleus after 4 h of treatment with DBP. On
the contrary, both after 2 h and 4 h, E2 induced ERα translocation from
the cytoplasm to the nucleus that appeared to be strongly positive
(Fig. 4).
3.4.2. Localization of ERβ
DBP did not aﬀect ERβ localization at any time of exposure: ERβ
was localized in the cytoplasm of LNCaP cells with no ﬂuorescent signal
in cell nuclei as in control cells. Instead E2 translocated ERβ from the
cytoplasm to the nucleus after 4 h (Fig. 5).
3.4.3. Localization of AR
AR localization was also investigated and data showed that DBP did
not interfere with AR localization which was perinuclear in both control
and treated cells after 30′, 2 h and 4 h of exposure. Only after 4 h of
treatment E2, AR translocated from the cytoplasm to the nucleus
(Fig. 6).
4. Discussion
Prostate gland plays a key role in male fertility. Its main function is
to produce secretion (20–30% of the total ejaculation) that provides
essential components for sperm quality and survival. Androgens have a
signiﬁcant function in prostate development and diﬀerentiation. Also
estrogens have been demonstrated to have direct eﬀects on prostate
gland development and adult homeostasis but small changes in their
levels might play a role in the etiology of prostatic diseases (McPherson
et al., 2008; Prins, Korach, 2008). Many epidemiological studies reveal
that chronic or intermittent exposure to diﬀerent classes of EDCs may
aﬀect the development and progression of prostate disorders (Van
Maele-Fabry et al., 2006).
Hence, the aim of this study is to investigate the eﬀects of dibu-
tylphthalate (DBP) on adenocarcinoma prostate cells (LNCaP); to
highlight a possible xenoestrogenic eﬀects on this cell line. The same
experiments have been performed also with the estrogen endogenous
17 β-estradiol (E2) in order to compare the eﬀects of these compounds.
First of all, we studied the eﬀects of DBP and E2 on cellular viability
and data obtained showed a reduced cellular viability with DBP
10−8 M; on the contrary E2 at 10−9 M stimulated cellular viability of
prostate cell line. Particularly interesting is the reduction of cellular
viability obtained at a low concentration of DBP, according to Hrubá
Fig. 3. Western blot analysis after 24 h of exposure to dibutylphthalate (DBP) 10−8 M and 17β- estradiol (E2) 10−9 M. The graphs represented the optical density (O.D.) ratio of
MCT4 (b), cyclin D1 (c), Bax (d), Bak (e), ERα (f), ERβ (g), AR (h) normalized on β actin. Look at the text for more details. (*p< 0,05; ** p<0,01; ***p< 0,001).
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Fig. 5. ERβ localization after 30´, 2 h and 4 h of
exposure to dibutylphthalate (DBP) 10−8 M and
17β-estradiol (E2) 10−9 M. ERβ appears to be lo-
calized in the cytoplasm in control cells. DBP did not
aﬀects ERβ localization. E2 induced a cytoplasm-
nucleus translocation only after 4 h. (Alexa Fluor
488) and nuclear staining (Hӧechst) were analyzed
by immunoﬂuorescence. Scale bar 10 µm.
Fig. 4. ERα localization after 30´, 2 h and 4 h of
exposure to dibutylphthalate (DBP) 10−8 M and
17β-estradiol (E2) 10−9 M. ERα appears to be lo-
calized in the cytoplasm in control cells. DBP in-
duced a cytoplasm-nuclear translocation after 4 h of
exposure. E2 switch cytoplasm-nucleus after 2 h and
4 h. (Alexa Fluor 488) and nuclear staining (Hӧechst)
were analyzed by immunoﬂuorescence. Scale bar
10 µm.
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et al. (2014) that showed DBP inhibition of LNCaP cell proliferation
(Hrubá et al., 2014). These data are in agreement with two common
EDC features: the biological eﬀect at low doses and the non monotonic
trend of the dose-response curve (Vandenberg et al., 2012). In this view,
Lee et al. (2014) have reported a positive inﬂuence of DBP on LNCaP
proliferation, but the authors have tested high concentrations (10−5
and 10−6 M) and more prolonged exposure times (Lee et al., 2014).
This apparent discrepancy is not surprising since EDCs such DBP may
exert opposite eﬀects at diﬀerent concentrations and exposure times.
Then, in order to evaluate expression of genes and proteins involved
in cellular proliferation and in cell cycle regulation, after 24 h of
treatment with DBP 10−8 M and E2 10−9 M, we performed two dif-
ferent approaches: qPCR and western blot analysis. DBP treatment did
not interfere with MCT4 gene and protein expression, instead E2 en-
hanced both of them. MCT4 belongs to the family of the mono-
carboxylate transporter and it is thought to be involved in the cellular
eﬄux of lactic acid/H+ (Dimmer et al., 2000); highly MCT4 expression
has been associated in cancer progression by promoting several onco-
genic processes (Sanità et al., 2014). Gene expression of Ki67, a well
known marker of cell proliferation, is decreased after treatment with
DBP but not after E2 treatment. Some studies have shown that estro-
gens might play a decisive role in some processes such as the devel-
opment of prostate cancer (Bosland, 2000; Griﬃths, 2000; Henderson,
Feigelson, 2000; Lee et al., 2014; Susa et al., 2015). DBP was able to
decrease gene and protein expression of cyclin D1, on the contrary E2
induced a strongly increase of cyclin D1 protein expression. Cyclin D1 is
an estrogen response target and it promotes G1/S phase transition of
cell cycle (Kastan, Bartek, 2004). These results are all in agreement with
the showed reduced proliferation caused by DBP and promoted by E2.
To better understand trough which pathway DBP induced a de-
creased cell viability, we evaluated protein expression of two diﬀerent
pro-apoptotic proteins involved in intrinsic apoptosis pathway: Bax and
Bak. DBP, contrarily to E2, strongly enhanced their expression,
suggesting a DBP involvement in programmed cell death processes.
Moreover, to assess estrogen (ER) and androgen (AR) receptors
participation, we evaluated the expression of ERs and AR with western
blot technique. We showed a reduced expression of ERα after treatment
with DBP and a signiﬁcant increase of its expression after E2 treatment.
It has been demonstrated that ERα appears to be involved in cellular
proliferation and carcinogenesis of prostate (Prins, Korach, 2008),
hence our results suggest that the anti-proliferative eﬀects of DBP.
Furthermore, DBP did not interfere with ERβ and AR expression, in-
stead E2 increased the expression of both of them. The E2 action on
both ERs and AR expression is in agreement with Susa et al. (2015) that
showed E2 involvement in the activation of AR pathway (Susa et al.,
2015).
Finally, we studied ERα, ERβ and AR localization after, 30 min, 2 h
and 4 h of treatment. DBP induced ERα cytoplasm-nucleus transloca-
tion only after 4 h of treatment; conversely E2 aﬀected ERα localization
after 2 h and 4 h. ERα nuclear translocation is linked to its activation
and it was not surprising that E2 had highest eﬀects than DBP because
of its best binding aﬃnity with ERs (Laws, 2000).
DBP did not interfere with ERβ and AR localization indicating that
its eﬀects on LNCaP cells are not linked with AR interaction as also
reported by Hrubá et al. (2014). On the contrary E2 was able to induce
ERβ and surprisingly also AR cytoplasm-nucleus translocation after 4 h.
It has been demonstrated that AR might be activated by other steroid
hormones and E2 shows aﬃnity for its LBD domain so it can be able to
activate transcription of AR target genes (Taplin et al., 1995; Yeah et.
al., 1998; Susa et al., 2015).
5. Conclusions
In conclusion, we demonstrated that DBP acts on LNCaP cells
through the activation of ERα pathway. Moreover, DBP exerts diﬀerent
eﬀects than E2. We showed that DBP reduced cell viability probably
Fig. 6. AR localization after 30′, 2 h and 4 h of
exposure to dibutylphthalate (DBP) 10−8 M and
17β-estradiol (E2) 10−9 M. DBP did not aﬀects AR
localization. E2 induced AR cytoplasm-nucleus
translocation only after 4 h. (Alexa Fluor 488) and
nuclear staining (Hӧechst) were analyzed by im-
munoﬂuorescence. Scale bar 10 µm.
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activating molecular pathway involved in the programmed cell death
processes as suggested by the obtained strong increase of both Bax and
Bak protein expression. Phthalates are only one of the component of the
mixture of EDCs which human population is non-stop exposed. Thus, it
is very important to compare the eﬀects of environmental compounds
with anti androgenic and anti estrogenic properties in order to explore
the crosstalk between diﬀerent hormonal signaling pathways.
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